A Proposed Oral-Liver-Pancreas Axis in Type 2 Diabetes: Linking Oral Dysbiosis, Hepatic Insulin Resistance, and Pancreatic Beta-Cell Stress.

Type 2 diabetes mellitus develops through the interaction of metabolic, inflammatory, and microbial processes that extend beyond the pancreas. Although the gut microbiota has received substantial attention, the oral microbiota may offer an additional, modifiable source of microbial and inflammatory signals. Periodontitis repeatedly exposes the circulation and gastrointestinal tract to bacteria, lipopolysaccharide, outer membrane vesicles, and host mediators. This narrative perspective asks whether oral dysbiosis may amplify pancreatic beta-cell stress through hepatic immunometabolic dysfunction, a hypothesis with direct support that requires causal testing. Human, animal, and mechanistic evidence was supplemented by targeted checks of PubMed-indexed records, PubMed Central, and publisher sources in September 2026, without a systematic search. In this hypothesis, oral dysbiosis may contribute to transient hematogenous dissemination and to an oral-gut route that can impair intestinal barrier function. The liver is proposed to act as an immunometabolic relay, converting microbial exposure into innate immune activation, hepatic insulin resistance, altered lipid handling, and circulating inflammatory or vesicular signals. Animal studies support oral-gut effects, whereas hepatic inflammatory mechanisms and beta-cell stress are supported largely by evidence not specific to oral exposure. These changes may increase the secretory, oxidative, and endoplasmic reticulum stress experienced by pancreatic beta cells. Direct evidence that oral microbes initiate beta-cell failure remains limited, and current human data are predominantly associative. The model, therefore, frames oral dysbiosis as a potential amplifier rather than a primary cause of type 2 diabetes. Longitudinal cohorts, microbial tracing studies, and intervention trials that measure periodontal, hepatic, inflammatory, and beta-cell outcomes together are needed to test this axis.